Evolutionary Genomics, Inc.

OTCPK:FNAM Stock Report

Market Cap: US$5.3k

Evolutionary Genomics Past Earnings Performance

Past criteria checks 0/6

There is insufficient data on Evolutionary Genomics's performance over the last few years.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Biotechs Industry Growth17.0%
Revenue growth raten/a
Return on equityn/a
Net Marginn/a
Last Earnings Update31 Dec 2022

Recent past performance updates

No updates

Recent updates

Revenue & Expenses Breakdown

How Evolutionary Genomics makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

OTCPK:FNAM Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 220-220
30 Sep 220-320
30 Jun 220-320
31 Mar 220-320
31 Dec 210-321
30 Sep 210-420
30 Jun 210-320
31 Mar 210-210
31 Dec 200-210
30 Sep 200-110
30 Jun 200-100
31 Mar 200-100
31 Dec 190-100
30 Sep 190-100
30 Jun 190-100
31 Mar 190-100
31 Dec 180-100
30 Sep 180-101
30 Jun 180-111
31 Mar 180-111
31 Dec 170-111
30 Sep 170-211
30 Jun 170-211
31 Mar 170-211
31 Dec 160-111
30 Sep 160-101
30 Jun 160011
31 Mar 160-101
31 Dec 150001
30 Sep 150-110
30 Jun 150-200
31 Mar 150-110
31 Dec 140-110
31 Dec 131000

Quality Earnings: Insufficient data to determine if FNAM has high quality earnings.

Growing Profit Margin: Insufficient data to determine if FNAM's profit margins have improved over the past year.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: Insufficient data to determine if FNAM's year-on-year earnings growth rate was positive over the past 5 years.

Accelerating Growth: Insufficient data to compare FNAM's past year earnings growth to its 5-year average.

Earnings vs Industry: Insufficient data to determine if FNAM's earnings growth over the past year exceeded the Biotechs industry average.


Return on Equity

High ROE: FNAM has a negative Return on Equity (0%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies